16.6
Tetanus is a severe neuromuscular disorder characterized by sustained muscle spasms caused by the bacterium Clostridium tetani.
It is caused when Clostridium tetani spores enter the host through wounds and germinate under anaerobic conditions in damaged or necrotic tissue.
The germinated vegetative cells remain localized at the infection site and proliferate.
These cells secrete tetanospasmin, a two-chain neurotoxin linked by a disulfide bond.
The toxin spreads to motor nerve endings and enters the motor neuron by endocytosis.
It then travels by retrograde axonal transport to the spinal cord in the central nervous system, where inhibitory interneurons take up the toxin.
After endocytosis, the toxin’s chains separate within the vesicle, and the light chain enters the cytoplasm.
The light chain cleaves synaptobrevin, a vesicle protein needed to release inhibitory neurotransmitters such as gamma-aminobutyric acid, or GABA, and glycine.
This prevents the release of inhibitory neurotransmitters. Without inhibition, motor neurons remain overactive, causing sustained muscle contraction or spastic paralysis, which manifests as muscle rigidity, facial spasms, and lockjaw.
Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.
Once introduced into the body, the spores germinate into vegetative cells. These cells secrete two exotoxins: tetanolysin and tetanospasmin. Tetanolysin is a hemolysin that promotes local tissue damage and helps create an anaerobic environment for bacterial growth, although its exact role in disease progression remains unclear. The second toxin, tetanospasmin—also known as tetanus toxin—is primarily responsible for the neurological symptoms of the disease.
Tetanospasmin is a 150-kilodalton A-B type neurotoxin, composed of a heavy (B) and a light (A) chain connected by a disulfide bond. The heavy chain binds to neuronal membrane components, including gangliosides such as GD1b and GT1b, and GPI-anchored proteins located within lipid rafts. After binding, the toxin is internalized at the neuromuscular junction and transported retrogradely along axons via dynein motors to the central nervous system.
Acidification activates the heavy chain within endosomes to translocate the light chain into the cytosol. Reduction of the disulfide bond releases the light chain, a zinc-dependent metalloprotease. This enzyme cleaves synaptobrevin—also known as VAMP—a SNARE protein essential for synaptic vesicle fusion.
This disruption prevents the release of inhibitory neurotransmitters GABA and glycine from Renshaw interneurons. Without this inhibition, motor neurons become hyperactive, leading to continuous, uncontrolled muscle contractions. Significantly, tetanospasmin affects only motor pathways; sensory function remains intact.
Clinically, this unopposed motor activity manifests as muscle stiffness and spasms, including lockjaw (trismus), facial grimacing (risus sardonicus), generalized rigidity, and, in severe cases, life-threatening spasms of the respiratory muscles.
Tetanus highlights how a single bacterial toxin can profoundly disrupt neural function. Fortunately, the disease is preventable through routine immunization with the tetanus toxoid vaccine, underscoring the importance of maintaining up-to-date booster shots.
Tetanus is a severe neuromuscular disorder characterized by sustained muscle spasms caused by the bacterium Clostridium tetani.
It is caused when Clostridium tetani spores enter the host through wounds and germinate under anaerobic conditions in damaged or necrotic tissue.
The germinated vegetative cells remain localized at the infection site and proliferate.
These cells secrete tetanospasmin, a two-chain neurotoxin linked by a disulfide bond.
The toxin spreads to motor nerve endings and enters the motor neuron by endocytosis.
It then travels by retrograde axonal transport to the spinal cord in the central nervous system, where inhibitory interneurons take up the toxin.
After endocytosis, the toxin’s chains separate within the vesicle, and the light chain enters the cytoplasm.
The light chain cleaves synaptobrevin, a vesicle protein needed to release inhibitory neurotransmitters such as gamma-aminobutyric acid, or GABA, and glycine.
This prevents the release of inhibitory neurotransmitters. Without inhibition, motor neurons remain overactive, causing sustained muscle contraction or spastic paralysis, which manifests as muscle rigidity, facial spasms, and lockjaw.
From Chapter 16:
Now Playing
Bacterial Diseases
48 Views
Bacterial Diseases
386 Views
Bacterial Diseases
175 Views
Bacterial Diseases
53 Views
Bacterial Diseases
41 Views
Bacterial Diseases
47 Views
Bacterial Diseases
59 Views
Bacterial Diseases
26 Views
Bacterial Diseases
124 Views
Bacterial Diseases
303 Views
Bacterial Diseases
158 Views
Bacterial Diseases
45 Views
Bacterial Diseases
107 Views
Bacterial Diseases
184 Views
Bacterial Diseases
262 Views